Assembly Biosciences, Inc. (NASDAQ:ASMB – Get Free Report) saw a large decline in short interest in August. As of August 31st, there was short interest totalling 125,500 shares, a decline of 20.8% from the August 15th total of 158,400 shares. Based on an average daily trading volume, of 88,600 shares, the short-interest ratio is currently 1.4 days.
Wall Street Analysts Forecast Growth
Separately, StockNews.com initiated coverage on Assembly Biosciences in a report on Sunday. They set a “hold” rating for the company.
Institutional Inflows and Outflows
Assembly Biosciences Price Performance
Shares of Assembly Biosciences stock traded up $0.08 on Monday, hitting $0.99. 350,243 shares of the company’s stock traded hands, compared to its average volume of 177,893. Assembly Biosciences has a one year low of $0.77 and a one year high of $1.91. The company has a fifty day moving average of $1.01 and a two-hundred day moving average of $1.04. The company has a market capitalization of $51.96 million, a price-to-earnings ratio of -0.56 and a beta of 0.74.
Assembly Biosciences (NASDAQ:ASMB – Get Free Report) last posted its quarterly earnings results on Wednesday, August 9th. The biopharmaceutical company reported ($0.32) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.29) by ($0.03). Equities research analysts anticipate that Assembly Biosciences will post -1.2 earnings per share for the current year.
Assembly Biosciences Company Profile
Assembly Biosciences, Inc, a biopharmaceutical company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's next-generation HBV core inhibitors include ABI-4334, which is in Phase 1a studies for the treatment of HBV; and ABI-H3733, which is in Phase 1b clinical study.
- Five stocks we like better than Assembly Biosciences
- How to Invest in the Best Canadian Stocks
- 5 Reasons Mullen Automotive is About to Turn a Corner
- The Significance of Brokerage Rankings in Stock Selection
- Qualcomm and Apple Forge Ahead with New Modem Partnership
- What is a Mid Cap Stock? How to Invest
- Can These 3 Healthcare Dividend Stocks Deliver Income Growth?
Receive News & Ratings for Assembly Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assembly Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.